SBIR/STTR Research Award
Novel Caenorhabditis Elegans Reagents
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ABEOME CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- GSGQJ6BDSHJ3
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): C. elegans is well established as a highly useful model organism. The 14th annual Biennial International C. elegans Conference held June 29th-July 3, 2003 elicited over 1151 abstracts published by over 2500 authors
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Therapeutic Approach to Hypercholesterolemia Using Anti PCSK Selected Immune Repertoires
- Novel Therapeutic Approach to Hypercholesterolemia Using Next-Generation DNA Sequ
- Development of a TAVI Device with a Reduced Crossing Profile
- Development of a transgenic mouse line engineered to permit selection and cloning
- Novel Markers on Human Embryonic Stem Cells
Research funding history
6 SBIR/STTR records share this UEI (2004–2016). Reported award amounts total $2,334,449. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services